{"id":3731,"date":"2012-10-22T20:28:26","date_gmt":"2012-10-23T00:28:26","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=3731"},"modified":"2012-10-22T21:29:57","modified_gmt":"2012-10-23T01:29:57","slug":"cepheid-breaks-losing-streak-gains-4-cphd","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731","title":{"rendered":"Cepheid Breaks Losing Streak, Gains 4% (CPHD)"},"content":{"rendered":"

Today, molecular diagnostics company Cepheid (NASDAQ: CPHD), which was on a decline after reporting a fiscal 2012 third-quarter loss and a lowered annual revenue and income guidance, went to the brink of hitting a new 52-week low price. After two successive days of declines last week, the share price opened at $30.31, a few notches above the 52-week low of $29.90 per share, and recovered from the negative territory to pose a 4.2% gain at the end of the day.<\/p>\n

The California-based company is involved in the development and manufacture of easy-to-use molecular systems and tests. Cepheid is focused on automating highly complex and time-consuming manual procedures such as genetic testing for organisms and developing applications for managing infectious diseases and cancer.<\/p>\n

On October 18, Cepheid reported an increase in the fiscal 2012 third-quarter revenue to $80.5 million from $70.2 million in the prior-year corresponding period. The net loss for the third-quarter was $21.3 million, or $0.32 per share, compared to a net profit of $1.92 million, or $0.03 per share, in the third-quarter of fiscal 2011. The company had paid a litigation settlement charge of $15.1 million during the third-quarter.<\/p>\n

Excluding the litigation settlement, employee stock-based compensation and amortization of purchased intangible assets, non-GAAP net income for the third-quarter decreased to $0.9 million from non-GAAP net income of $7.6 million in the year-ago corresponding quarter. According to FactSet,\u00a0analysts expected<\/a> the company to report $80.7 million in revenue and income of $0.01 per share\u00a0for the reported quarter.<\/p>\n

From a low of $34.53 per share in the last week of January 2012, Cepheid rose to $44.91 per share on February 6, owing to the fiscal 2011 fourth-quarter results that beat analysts\u2019 estimates<\/a>\u00a0and a fiscal 2012 full-year guidance that was way better than what the analysts had expected. However, a cut in fiscal 2012 full-year guidance issued on July 19 brought the share price back to $32.13 per share on July 24. On August 6, Cepheid announced a series of agreements<\/a> with the Bill & Melinda Gates Foundation, the United States President’s Emergency Plan for AIDS Relief (PEPFAR), the United States Agency for International Development (USAID) and UNITAID to buy-down the price of the Xpert MTB\/RIF test for High Burden Developing Countries (HBDCs). The news propelled the share price back to $40.12 per share on September 7.<\/p>\n

On September 26, Cepheid issued a fiscal 2012 third-quarter revenue warning that led the fall in the share price to $34.48 on October 1. Following the report of a third-quarter loss, the share price plunged to $30.59.<\/p>\n

For the fiscal year 2012 ending December 2012, the company now expects to report total revenue of approximately $333 million, which is at the lower end of the previously issued revenue guidance range of $333 million to $347 million. Cepheid also lowered its full-year income guidance from break even to $0.04 per share to a net loss in the range of $0.42 to $0.40 per share. The company anticipates a non-GAAP net income in the range of $0.21 to $0.23 per share.\u00a0On an average, analysts are expecting a net income of $0.01 per share and revenue of $332.9 million.<\/p>\n

Cepheid ended the day at $31.87 per share, up $1.28 or 4.2% on a volume of 942,592 shares.<\/p>\n","protected":false},"excerpt":{"rendered":"

Today, molecular diagnostics company Cepheid (NASDAQ: CPHD), which was on a decline after reporting a fiscal 2012 third-quarter loss and a lowered annual revenue and […]<\/p>\n","protected":false},"author":12,"featured_media":3743,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[260,264,4],"tags":[483],"stock_ticker":[],"class_list":["post-3731","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-advancers","category-health","category-nasdaq-high-profiles","tag-cphd","entry"],"acf":[],"yoast_head":"\nCepheid Breaks Losing Streak, Gains 4% (CPHD) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cepheid Breaks Losing Streak, Gains 4% (CPHD) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Today, molecular diagnostics company Cepheid (NASDAQ: CPHD), which was on a decline after reporting a fiscal 2012 third-quarter loss and a lowered annual revenue and […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2012-10-23T00:28:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2012-10-23T01:29:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/10\/Screen-Shot-2012-10-22-at-8.00.37-PM.png\" \/>\n\t<meta property=\"og:image:width\" content=\"370\" \/>\n\t<meta property=\"og:image:height\" content=\"216\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Steve Hackney\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Hackney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731\"},\"author\":{\"name\":\"Steve Hackney\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\"},\"headline\":\"Cepheid Breaks Losing Streak, Gains 4% (CPHD)\",\"datePublished\":\"2012-10-23T00:28:26+00:00\",\"dateModified\":\"2012-10-23T01:29:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731\"},\"wordCount\":498,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/10\/Screen-Shot-2012-10-22-at-8.00.37-PM.png\",\"keywords\":[\"CPHD\"],\"articleSection\":[\"Advancers\",\"Health\",\"NASDAQ high profiles\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731\",\"name\":\"Cepheid Breaks Losing Streak, Gains 4% (CPHD) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/10\/Screen-Shot-2012-10-22-at-8.00.37-PM.png\",\"datePublished\":\"2012-10-23T00:28:26+00:00\",\"dateModified\":\"2012-10-23T01:29:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/10\/Screen-Shot-2012-10-22-at-8.00.37-PM.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/10\/Screen-Shot-2012-10-22-at-8.00.37-PM.png\",\"width\":370,\"height\":216},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cepheid Breaks Losing Streak, Gains 4% (CPHD)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\",\"name\":\"Steve Hackney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"caption\":\"Steve Hackney\"},\"description\":\"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cepheid Breaks Losing Streak, Gains 4% (CPHD) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731","og_locale":"en_US","og_type":"article","og_title":"Cepheid Breaks Losing Streak, Gains 4% (CPHD) - Wall Street PR","og_description":"Today, molecular diagnostics company Cepheid (NASDAQ: CPHD), which was on a decline after reporting a fiscal 2012 third-quarter loss and a lowered annual revenue and […]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2012-10-23T00:28:26+00:00","article_modified_time":"2012-10-23T01:29:57+00:00","og_image":[{"width":370,"height":216,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/10\/Screen-Shot-2012-10-22-at-8.00.37-PM.png","type":"image\/png"}],"author":"Steve Hackney","twitter_misc":{"Written by":"Steve Hackney","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731"},"author":{"name":"Steve Hackney","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867"},"headline":"Cepheid Breaks Losing Streak, Gains 4% (CPHD)","datePublished":"2012-10-23T00:28:26+00:00","dateModified":"2012-10-23T01:29:57+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731"},"wordCount":498,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/10\/Screen-Shot-2012-10-22-at-8.00.37-PM.png","keywords":["CPHD"],"articleSection":["Advancers","Health","NASDAQ high profiles"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731","url":"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731","name":"Cepheid Breaks Losing Streak, Gains 4% (CPHD) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/10\/Screen-Shot-2012-10-22-at-8.00.37-PM.png","datePublished":"2012-10-23T00:28:26+00:00","dateModified":"2012-10-23T01:29:57+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/10\/Screen-Shot-2012-10-22-at-8.00.37-PM.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2012\/10\/Screen-Shot-2012-10-22-at-8.00.37-PM.png","width":370,"height":216},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cepheid-breaks-losing-streak-gains-4-cphd-3731#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Cepheid Breaks Losing Streak, Gains 4% (CPHD)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867","name":"Steve Hackney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","caption":"Steve Hackney"},"description":"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/3731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=3731"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/3731\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/3743"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=3731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=3731"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=3731"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=3731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}